VGX™ Pharmaceuticals

	10/15/2008 VGX Pharmaceuticals Presents Non-human Primate Study Data at AIDS Vaccine 2008 Conference
	10/7/2008 VGX Animal Health announces the commercialization of its LifeTide™ SW 5 GHRH gene therapy product for pigs in Australia
	10/1/2008 VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation

	October 13-16, 2008 Capetown, S. Africa AIDS Vaccine Conference
	September 23-25, 2008 Milan, Italy Sixth World Congress on Vaccines, Immunisation and Immunotherapy